all AI news
Isomorphic signs drug discovery deals with Eli Lilly and Novartis
Jan. 8, 2024, 9:04 a.m. | Leigh Mc Gowran
Silicon RepublicSilicon Republic www.siliconrepublic.com
The company aims to use the power of AI to tackle various diseases and could receive nearly $3bn from its new research collaborations.
Read more: Isomorphic signs drug discovery deals with Eli Lilly and Novartis
ai alphabet collaborations deals deals done discovery diseases drug discovery eli lilly funding and investment innovation novartis power research the company
More from www.siliconrepublic.com / Silicon RepublicSilicon Republic
Microsoft faces EU pressure but avoids UK probe
3 days, 4 hours ago |
www.siliconrepublic.com
Sony Music warns AI companies over the use of its songs
3 days, 10 hours ago |
www.siliconrepublic.com
KPMG to create 200 jobs from new EU AI Hub in Dublin
3 days, 10 hours ago |
www.siliconrepublic.com
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US